Status:
UNKNOWN
Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening
Lead Sponsor:
The Netherlands Cancer Institute
Collaborating Sponsors:
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Erasmus Medical Center
Conditions:
CRC
Advanced Neoplasia
Eligibility:
All Genders
55-75 years
Brief Summary
The primary goal of the population-based colorectal (CRC) screening is early detection and interception of CRC and its precursors to decrease CRC-related morbidity and mortality. To improve current CR...
Detailed Description
Background: The primary goal of population-based CRC screening is early detection and interception of CRC and its precursors to decrease CRC-related morbidity and mortality. New tests, with higher se...
Eligibility Criteria
Inclusion
- Individuals of the Dutch population suitable for CRC screening (age between 55 and 75 years old) will be randomly selected.
- The participants will be invited in phases and are selected out of different age groups.
- The selected participants will participate in the population CRC screening program for either the first, second, third or fourth time.
Exclusion
- Collection of stool not complete for both tests (FIT and mtFIT)
Key Trial Info
Start Date :
March 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
14712 Patients enrolled
Trial Details
Trial ID
NCT05314309
Start Date
March 25 2022
End Date
May 31 2023
Last Update
January 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Netherlands Cancer Institute
Amsterdam, Netherlands